The Economic Burden of HR+/HER2- Breast Cancer: What Patients Need to Know A diagnosis of HR+/HER2- breast cancer not only brings emotional and physical challenges but also significant economic burdens. Understanding these financial implications is crucial for patients and their families as they navigate their treatment journey. Here, we explore the various costs associated with HR+/HER2- breast cancer, the potential financial impact on patients, and strategies to...
0 Distribuiri
304 Views
0 previzualizare